154 related articles for article (PubMed ID: 31897589)
1. Preclinical evaluation of [
Onega M; Parker CA; Coello C; Rizzo G; Keat N; Ramada-Magalhaes J; Moz S; Tang SP; Plisson C; Wells L; Ashworth S; Slack RJ; Vitulli G; Wilson FJ; Gunn R; Lukey PT; Passchier J
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):958-966. PubMed ID: 31897589
[TBL] [Abstract][Full Text] [Related]
2. A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of
Keat N; Kenny J; Chen K; Onega M; Garman N; Slack RJ; Parker CA; Lumbers RT; Hallett W; Saleem A; Passchier J; Lukey PT
J Nucl Med Technol; 2018 Jun; 46(2):136-143. PubMed ID: 29438002
[TBL] [Abstract][Full Text] [Related]
3. Clinical quantification of the integrin αvβ6 by [
Lukey PT; Coello C; Gunn R; Parker C; Wilson FJ; Saleem A; Garman N; Costa M; Kendrick S; Onega M; Kang'ombe AR; Listanco A; Davies J; Ramada-Magalhaes J; Moz S; Fahy WA; Maher TM; Jenkins G; Passchier J; Marshall RP
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):967-979. PubMed ID: 31814068
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Characterization of the αvβ6 Integrin Binding and Internalization Kinetics of the Foot-and-Mouth Disease Virus Derived Peptide A20FMDV2.
Slack RJ; Hafeji M; Rogers R; Ludbrook SB; Marshall JF; Flint DJ; Pyne S; Denyer JC
Pharmacology; 2016; 97(3-4):114-25. PubMed ID: 26734728
[TBL] [Abstract][Full Text] [Related]
5. Integrin αvβ6 Positron Emission Tomography Imaging in Lung Cancer Patients Treated With Pulmonary Radiation Therapy.
Saleem A; Helo Y; Win Z; Dale R; Cook J; Searle GE; Wells P
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):370-376. PubMed ID: 32060008
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.
Hausner SH; Bauer N; Hu LY; Knight LM; Sutcliffe JL
J Nucl Med; 2015 May; 56(5):784-90. PubMed ID: 25814519
[TBL] [Abstract][Full Text] [Related]
7. A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor.
Maher TM; Simpson JK; Porter JC; Wilson FJ; Chan R; Eames R; Cui Y; Siederer S; Parry S; Kenny J; Slack RJ; Sahota J; Paul L; Saunders P; Molyneaux PL; Lukey PT; Rizzo G; Searle GE; Marshall RP; Saleem A; Kang'ombe AR; Fairman D; Fahy WA; Vahdati-Bolouri M
Respir Res; 2020 Mar; 21(1):75. PubMed ID: 32216814
[TBL] [Abstract][Full Text] [Related]
8. Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin alphavbeta6 expression with positron emission tomography.
Hausner SH; DiCara D; Marik J; Marshall JF; Sutcliffe JL
Cancer Res; 2007 Aug; 67(16):7833-40. PubMed ID: 17699789
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide.
Hausner SH; Bauer N; Sutcliffe JL
Nucl Med Biol; 2014 Jan; 41(1):43-50. PubMed ID: 24267053
[TBL] [Abstract][Full Text] [Related]
10. Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model.
Hausner SH; Abbey CK; Bold RJ; Gagnon MK; Marik J; Marshall JF; Stanecki CE; Sutcliffe JL
Cancer Res; 2009 Jul; 69(14):5843-50. PubMed ID: 19549907
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a
Ui T; Ueda M; Higaki Y; Kamino S; Sano K; Kimura H; Saji H; Enomoto S
Bioorg Med Chem; 2020 Jan; 28(1):115189. PubMed ID: 31740201
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the power of foot-and-mouth-disease virus for targeting integrin alpha-v beta-6 for the therapy of cancer.
Meecham A; Marshall J
Expert Opin Drug Discov; 2021 Jul; 16(7):737-744. PubMed ID: 33533659
[No Abstract] [Full Text] [Related]
13. Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosis.
John AE; Luckett JC; Tatler AL; Awais RO; Desai A; Habgood A; Ludbrook S; Blanchard AD; Perkins AC; Jenkins RG; Marshall JF
J Nucl Med; 2013 Dec; 54(12):2146-52. PubMed ID: 24167080
[TBL] [Abstract][Full Text] [Related]
14. PET/CT Imaging of NSCLC with a α
Flechsig P; Lindner T; Loktev A; Roesch S; Mier W; Sauter M; Meister M; Herold-Mende C; Haberkorn U; Altmann A
Mol Imaging Biol; 2019 Oct; 21(5):973-983. PubMed ID: 30671741
[TBL] [Abstract][Full Text] [Related]
15. 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6.
Hackel BJ; Kimura RH; Miao Z; Liu H; Sathirachinda A; Cheng Z; Chin FT; Gambhir SS
J Nucl Med; 2013 Jul; 54(7):1101-5. PubMed ID: 23670900
[TBL] [Abstract][Full Text] [Related]
16. Optimized serum stability and specificity of an αvβ6 integrin-binding peptide for tumor targeting.
Cardle II; Jensen MC; Pun SH; Sellers DL
J Biol Chem; 2021; 296():100657. PubMed ID: 33857478
[TBL] [Abstract][Full Text] [Related]
17. High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6.
Saha A; Ellison D; Thomas GJ; Vallath S; Mather SJ; Hart IR; Marshall JF
J Pathol; 2010 Sep; 222(1):52-63. PubMed ID: 20629113
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
